Can the effects of antidepressants be observed in the first two weeks of treatment?

Neuropsychopharmacology

Volumn 15, Issue 4, 1996, Pages 390-394

  Quitkin, Frederic M ^a,b   McGrath, Patrick J ^a   Stewart, Jonathan W ^a   Taylor, Bonnie P ^a   Klein, Donald F ^a  

^a The New York Presbyterian Hospital   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Antidepressants; Depressive disorder; Placebo; Response time; Treatment outcome

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; IMIPRAMINE; MIANSERIN; PHENELZINE; SELEGILINE; TRANYLCYPROMINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; DRUG RESPONSE; HUMAN; MELANCHOLIA; META ANALYSIS; PRIORITY JOURNAL; REVIEW; TIME;

EID: 0030271735     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00272-F     Document Type: Article

References (22)

1. Bielski RJ, Friedel RO (1976): Prediction of tricyclic antidepressant response. Arch Gen Psychiatry 33:1479-1489
2. Casper RC, Katz MM, Bowden CL, Davis JM, Koslow SH, Hanin I (1994): The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine. J Affect Disord 31:151-164
3. Cohen J (1988): Statistical Power Analysis for the Behavioral Science. New York, Academic Press
4. Coryell W, Coppen A, Zeigler VE, Biggs JT (1982): Early improvement as a predictor of response to amitriptyline and nortriptyline: A comparison of 2 patient samples. Psychol Med 12:135-139
5. Janicak PG, Davis JM, Preskorn SH, Ayd FJ Jr (1993): Principles and Practice of Psychopharmacotherapy, Baltimore, Williams & Wilkins
6. Joyce PR, Paykel ED (1989): Predictors of drug response in depression. Arch Gen Psychiatry 46:88-89
7. Katz MM, Koslow SH, Maas JW, Frazer A, Bowden CL, Casper R, Croughan J, Kocsis J, Redmond E Jr (1987): The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 17:297-309
8. Katz MM, Maas J, Frazer A, Koslow SH (1994): Onset of antidepressant activity, the structure of depression and multiple drug actions. Paper presented at ACNP, Puerto Rico
9. Klein DF, Gittelman-Klein R, Quitkin FM, Rifkin A (1980): Diagnosis and Drug Treatment of Psychiatric Disorders. Baltimore, Williams & Wilkins
10. Klerman GL, Cole JO (1965): Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol Rev 17:101-141
11. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF (1988): Antidepressant specificity in atypical depression. Arch Gen Psychiatry 45:129-137
12. McGrath PJ, Quitkin FM, Harrison W, Stewart JW (1984): Treatment of melancholia with tranylcypromine. Am J Psychiatry 141:286-2894
13. McGrath PJ, Rabkin JG, Stewart JW, Harrison W, Quitkin FM, Markowitz J (1985): Placebo-controlled study of mianserin in depressed outpatients. Neuropsychobiology 14(3):128-132
14. McGrath PJ, Stewart JW, Nunes EV, Ocepek-Welikson K, Rabkin JG, Quitkin KM, Klein DF (1993): A double-blind cross over trial of imipramine and phenelzine for outpatients with treatment refractory depression. Am J Psychiatry 150(1):118-123
15. Quitkin FM, Liebowitz MR, Stewart JW, McGrath PJ, Harrison W, Rabkin JG, Markowitz J, Davies SO (1984): L-Deprenyl in atypical depressives. Arch Gen Psychiatry 41:777-781
16. Quitkin FM, Rabkin JG, Markowitz JM, Stewart JW, McGrath PJ and Harrison W (1987): Use of pattern analysis to identify true drug response: A replication. Arch Gen Psychiatry 44:259-264
17. Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Wager SG, Nunes E, Rabkin JG, Tricamo E, Markowitz J, Klein DF (1989): Phenelzine and imipramine in mood reactive depressives: Further delineation of the syndrome of atypical depression. Arch Gen Psychiatry 46:787-793
18. Rothman KJ, Michels KB (1994): The continuing unethical use of placebo controls. N Engl J Med 331(6):394-398
19. Stassen HH, Angst J, Delini-Stula A (1994): Severity at baseline and onset of improvement in depression. Metaanalysis of imipramine and moclobemide versus placebo. Eur Psychiatry 9:129-136
20. Stewart J, Quitkin FM, Fyer A, Rifkin A, McGrath P, Liebowitz M, Rosnick L, Klein DF (1980): Efficacy of desipramine in endogenmorphically depressed patients. J Affect Disord 2:165-176
21. Stewart JW, Quitkin FM, McGrath PJ, Liebowitz MR, Klein DF (1981): Efficacy of desipramine in mildly depressed patients: A double-blind placebo-controlled trial. Psychopharmacol Bull 17(1):159-161
22. Winokur G (1980): What to do? Or what do we owe our residents? Biological Psychiatry 15:599-611